Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden
Abstract
Authors
J Wlodarczyk E Hunsche B Silberberg D Kemp B Anell K Corcoran R Minacori M Stevenson A Beaudet